Literature DB >> 2660646

Human T-lymphotrophic viruses and diseases of long latency.

W A Blattner1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2660646     DOI： 10.7326/0003-4819-111-1-4

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

2.  Detection of human T-lymphotropic virus-like particles in cultures of peripheral blood lymphocytes from patients with mycosis fungoides.

Authors:  D Zucker-Franklin; E E Coutavas; M G Rush; D C Zouzias
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.

Authors:  N M Clark; M J Smith; J M Hilfinger; D M Markovitz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

4.  Human T-cell lymphotropic virus type 1 tax among American blood donors.

Authors:  D Zucker-Franklin; B A Pancake
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

5.  A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep.

Authors:  Carole Pomier; Maria Teresa Sanchez Alcaraz; Christophe Debacq; Agnes Lançon; Pierre Kerkhofs; Lucas Willems; Eric Wattel; Franck Mortreux
Journal:  Retrovirology       Date:  2009-04-03       Impact factor: 4.602

6.  Prevalence and risk factors of HTLV-1/2 and other blood borne infectious diseases among blood donors in Yaounde Central Hospital, Cameroon.

Authors:  Michel Kengne; Dorine Carol Wouado Tsata; Thérèse Ndomgue; Julius Mbekem Nwobegahay
Journal:  Pan Afr Med J       Date:  2018-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.